The Office of Personnel Management is directing insurance carriers in federal health benefits programs to tighten fraud controls, opening a new front in the Trump administration's campaign against waste and corruption in government-funded health care. OPM sent new compliance expectations to carriers on Wednesday, Fox News Digital first reported, with mandates covering fraud prevention, payment reviews, pharmacy benefit oversight, subcontractor accountability, and audits.
The move targets a $70 billion system that covers more than 8.2 million people, federal employees, retirees, their families, and postal workers, and comes just weeks after the Government Accountability Office told OPM it needed to do more to manage fraud risks in the Federal Employees Health Benefits program.
That GAO report, published in July 2025, cataloged a range of vulnerabilities: benefit card sharing, improper inducements, insufficient or fraudulent documentation, kickbacks, marketing fraud, theft of personally identifiable information, provider ineligibility, and self-referrals. In short, the watchdog found a system riddled with openings for bad actors, and an agency that had not kept pace.
The compliance expectations apply to insurance carriers in both the Federal Employees Health Benefits program and the Postal Service Health Benefits program. Carriers must now strengthen fraud prevention measures, tighten payment reviews, and improve oversight of pharmacy benefit managers, the middlemen who negotiate drug prices and process claims between insurers, pharmacies, and patients.
OPM is also requiring greater subcontractor accountability and more rigorous auditing and reporting. The agency is building a data science and audit team alongside its inspector general to review anonymized claims data and detect fraud, waste, and overbilling before the money goes out the door rather than chasing it afterward.
OPM Director Scott Kupor framed the action as a direct obligation to the people who fund the system:
"Working alongside the White House Task Force to Eliminate Fraud, OPM is taking additional steps to safeguard the premiums paid by federal employees and taxpayers, protect beneficiaries, and ensure health insurance companies are meeting the highest standards of accountability."
White House Task Force Executive Director Scott Brady echoed that message:
"OPM is a valuable partner and leader on the Task Force. The steps taken today will protect taxpayers and our federal workforce."
The OPM action does not exist in isolation. Vice President JD Vance leads the White House Task Force to Eliminate Fraud, and the administration has spent months escalating pressure on health care fraud across multiple programs. In April, the Centers for Medicare and Medicaid Services directed all 50 states to submit plans to revalidate high-risk Medicaid providers, including those operating under less rigorous enrollment standards or without a National Provider Identifier.
In May, Vance went further. During a news conference, the vice president warned that states could lose federal funding if they fail to aggressively pursue Medicaid fraud. That was not a suggestion. It was a condition.
The scale of the problem justifies the urgency. The FEHB program alone cost the government and enrollees roughly $70 billion in fiscal 2024, according to the GAO. Medicaid fraud cases have become national flashpoints. Minnesota's $250 million "Feeding Our Future" scheme exposed how easily federal nutrition dollars could be siphoned through fraudulent claims. A House GOP task force has launched probes into alleged Medicaid fraud in Ohio that could reach $250 billion.
Pennsylvania offers a fresh example of what happens when fraud controls fail. Pennsylvania Attorney General Dave Sunday recently detailed a $12 million Medicaid bust involving a Philadelphia pharmacy that allegedly collected millions in Medicaid reimbursements for prescriptions it never fulfilled. The case illustrates the kind of scheme that thrives in systems where documentation requirements are lax and oversight is reactive.
These are not victimless crimes. Every fraudulent claim paid by a federal health program comes out of premiums paid by workers and tax dollars appropriated by Congress. When a pharmacy bills Medicaid for prescriptions it never filled, patients who needed those medications may never have received them. When a provider submits false documentation, the cost lands on every enrollee whose premiums rise to cover the losses.
The inclusion of pharmacy benefit managers in OPM's compliance push is notable. PBMs occupy a powerful and opaque position in the health care supply chain. They negotiate rebates with drug manufacturers, set formularies, and process claims, often with limited transparency into how they profit from the spread between what they charge insurers and what they pay pharmacies.
Critics on both sides of the aisle have questioned whether PBMs drive up costs rather than control them. By directing carriers to improve oversight of these middlemen, OPM is signaling that the administration views the PBM layer as a fraud and waste risk, not just a pricing concern.
The July 2025 GAO report, identified as GAO-25-106885, laid out the fraud risks in the FEHB program with unusual specificity. The watchdog did not accuse OPM of ignoring fraud entirely, but it made clear the agency's existing controls were insufficient for the scope of the threat.
Benefit card sharing alone opens the door to unauthorized individuals receiving care on someone else's plan. Kickbacks and self-referrals corrupt the provider network from the inside. Marketing fraud draws enrollees into plans or services designed to generate billing rather than deliver care.
OPM's response, building an internal data science capability and issuing binding compliance expectations, suggests the agency is treating the GAO findings as a mandate rather than a recommendation. Whether the new measures carry enforceable penalties for carriers that fall short remains an open question. The compliance expectations set standards, but the enforcement mechanism has not been publicly detailed.
Several questions hang over the initiative. Which specific carriers received the new expectations? What happens if a carrier fails to meet them, does OPM have the authority to pull a contract, impose fines, or refer cases for prosecution? What claims data fields will the new audit team examine, and how will patient privacy be maintained while the analysis proceeds?
The administration has not named specific carriers or PBMs under scrutiny. That may be deliberate, the compliance push appears designed to apply pressure across the board rather than single out individual companies. But accountability requires specifics eventually. Broad mandates without visible enforcement become suggestions.
Federal employees pay premiums into the FEHB and Postal Service Health Benefits programs alongside the government's share. When fraud inflates costs, those premiums rise. When overbilling goes undetected, taxpayers absorb the loss. The $70 billion annual price tag for FEHB alone means even a small percentage of fraud translates into billions of dollars.
The administration's broader posture, from CMS revalidation orders to Vance's funding threats to OPM's carrier mandates, represents the most coordinated federal push against health care fraud in recent memory. Whether it produces results will depend on follow-through, not announcements.
For years, Washington treated health care fraud as a cost of doing business. The bill always landed on the same people, workers, retirees, and taxpayers who had no say in how the money was spent. It is long past time someone sent it back.